Identification and Evaluation of a Potent Novel ATR Inhibitor, NU6027, in Breast and Ovarian Cancer Cell Lines

British Journal of Cancer - United Kingdom
doi 10.1038/bjc.2011.243
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Springer Science and Business Media LLC

Related search

PARP Inhibitor Treatment in Ovarian and Breast Cancer

Current Problems in Cancer
Cancer ResearchOncology
2011English

Novel PI3K and mTOR Inhibitor NVP-BEZ235 Radiosensitizes Breast Cancer Cell Lines Under Normoxic and Hypoxic Conditions

Breast Cancer: Basic and Clinical Research
Cancer ResearchOncology
2014English

Anti-Cancer Effects of Erlotinib (EGFR Inhibitor) on Metastasis of Breast Cancer Cell Lines

Multidisciplinary Cancer Investigation
2017English

Guanylate-Binding Protein-1 Protects Ovarian Cancer Cell Lines but Not Breast Cancer Cell Lines From Killing by Paclitaxel

Biochemical and Biophysical Research Communications
BiochemistryCell BiologyMolecular BiologyBiophysics
2016English

A Novel Synthetic Ursolic Acid Derivative Inhibits Growth and Induces Apoptosis in Breast Cancer Cell Lines

Oncology Letters
Cancer ResearchOncology
2017English

Identification of Novel GRM1 Mutations and Single Nucleotide Polymorphisms in Prostate Cancer Cell Lines and Tissues

PLoS ONE
Multidisciplinary
2014English

Identification of a Novel Rhabdovirus in Spodoptera Frugiperda Cell Lines

Journal of Virology
Insect ScienceImmunologyMicrobiologyVirology
2014English

Anti-Apoptotic Effects of PCP4/PEP19 in Human Breast Cancer Cell Lines: A Novel Oncotarget

Oncotarget
Oncology
2014English

Discovery of Novel Potent VEGFR2 Inhibitors Exerting Significant Antiproliferative Activity Against Cancer Cell Lines

English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy